aTyr Pharma Inc. (LIFE)
NASDAQ: LIFE
· Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 10:00 PM
aTyr Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.19M | -64.54M | -57.08M | -53.94M | -50.4M | -43.16M | -45.06M | -45.14M | -45.34M | -46.38M | -40.8M | -38.78M | -33.78M | -30.15M | -29.08M | -25.14M |
Depreciation & Amortization | -1.04M | 1.54M | 2.17M | 2.76M | 2.74M | 3.03M | 2.45M | 2.15M | 1.7M | 1.32M | 1.23M | 1.3M | 1.3M | 1.23M | 1.2M | 1.21M |
Stock-Based Compensation | 237K | 2.96M | 2.8M | 2.72M | 2.6M | 2.55M | 2.5M | 2.36M | 2.15M | 1.96M | 1.79M | 1.67M | 1.61M | 1.54M | 1.42M | 1.4M |
Other Working Capital | 5.39M | n/a | -5.98M | -6.7M | 2.7M | -8.75M | -12.03M | -11.89M | -13.47M | -3.14M | -1.12M | -535K | -535K | -2.88M | -2.62M | -3.44M |
Other Non-Cash Items | -16.76M | -10.92M | 7.95M | 19.29M | 19.9M | 22.22M | 11.01M | -126K | 441K | 699K | 611K | 469K | 372K | 165K | 213K | 268K |
Deferred Income Tax | 9.4M | n/a | -10.85M | -23.08M | -23.08M | -24.54M | -12.23M | n/a | n/a | n/a | n/a | n/a | n/a | 48K | 118K | 131K |
Change in Working Capital | -549K | n/a | -2.97M | -2.99M | 15.01M | 7.37M | 6.08M | 8.4M | -833K | 2.8M | -1.62M | -2.04M | -2.59M | -3.22M | 1.65M | -1.05M |
Operating Cash Flow | -1.92M | -55.99M | -43M | -55.01M | -33.22M | -32.53M | -35.25M | -32.36M | -41.89M | -39.6M | -38.79M | -37.37M | -33.08M | -30.39M | -24.48M | -23.19M |
Capital Expenditures | 568K | -40K | -591K | -2.99M | -4.21M | -5.32M | -5.19M | -2.84M | -1.64M | -540K | -175K | -218K | -192K | -179K | -130K | -53K |
Cash Acquisitions | 40.61M | n/a | -22.77M | -22.76M | 14.17M | 32.53M | 37.48M | 27.45M | -9.48M | -10.01M | -10.02M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 26.24M | -43.04M | -59.61M | -82.09M | -106.98M | -122.31M | -99.64M | -88.34M | -42.12M | -74.82M | -97.66M | -100.83M | -126.51M | -69.71M | -43.08M | -43.66M |
Sales Maturities Of Investments | -44.31M | 64.24M | 81.05M | 101.75M | 91.05M | 91.66M | 85.13M | 85.63M | 90.83M | 71.03M | 58.01M | 47.28M | 35.08M | 30.87M | 20.77M | 15.8M |
Other Investing Acitivies | -21.22M | 2.15M | 22.77M | 21.01M | -15.91M | -34.28M | -18.14M | -6.36M | 30.73M | 31.32M | 10.24M | 219K | 50K | 6K | 15K | 15K |
Investing Cash Flow | 1.89M | 23.32M | 20.84M | 16.69M | -20.13M | -35.95M | -19.68M | -5.55M | 47.24M | -4.1M | -39.6M | -53.55M | -91.57M | -39.02M | -22.43M | -27.9M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 63K | 78K | 79K | 105K | 105K | 130K | 65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 48.4M | 13.84M | 16.45M | 24.46M | 66.23M | 61.11M | 61.45M | 53.47M | 5.45M | 4.56M | 85.42M | 86.65M | 110.03M | 111M | 27.46M | 24.22M |
Financial Cash Flow | 38.41M | 21.02M | 16.45M | 24.46M | 66.23M | 61.11M | 61.45M | 53.47M | 5.45M | 4.56M | 85.42M | 86.65M | 110.03M | 111M | 27.46M | 24.22M |
Net Cash Flow | -8.43M | 4.33M | -5.74M | -10.7M | 12.85M | -7.36M | 6.51M | 12.37M | 10.81M | -39.14M | 7.03M | -4.26M | -14.62M | 41.59M | -19.44M | -26.87M |
Free Cash Flow | -1.36M | -56.03M | -43.59M | -58M | -37.44M | -37.84M | -40.44M | -35.2M | -43.53M | -40.14M | -38.97M | -37.59M | -33.27M | -30.57M | -24.61M | -23.24M |